Amniotics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was SEK 1.96 million compared to SEK 0.05 million a year ago. Net loss was SEK 6.79 million compared to SEK 10.68 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.66 a year ago.
For the six months, revenue was SEK 2.27 million compared to SEK 0.086 million a year ago. Net loss was SEK 18.38 million compared to SEK 21.69 million a year ago. Basic loss per share from continuing operations was SEK 0.25 compared to SEK 1.35 a year ago.